| Two for the price of one: Attacking the energetic-metabolic hub of mycobacteria to produce new chemotherapeutic agents K Hards, C Adolph, LK Harold, MB McNeil, CY Cheung, A Jinich, ... Progress in biophysics and molecular biology 152, 35-44, 2020 | 27 | 2020 |
| An amiloride derivative is active against the F1Fo-ATP synthase and cytochrome bd oxidase of Mycobacterium tuberculosis K Hards, CY Cheung, N Waller, C Adolph, L Keighley, ZS Tee, LK Harold, ... Communications Biology 5 (1), 166, 2022 | 25 | 2022 |
| Impaired succinate oxidation prevents growth and influences drug susceptibility in Mycobacterium tuberculosis C Adolph, MB McNeil, GM Cook Mbio 13 (4), e01672-22, 2022 | 15 | 2022 |
| Uncovering interactions between mycobacterial respiratory complexes to target drug-resistant Mycobacterium tuberculosis MB McNeil, CY Cheung, NJE Waller, C Adolph, CL Chapman, NEJ Seeto, ... Frontiers in Cellular and Infection Microbiology 12, 980844, 2022 | 5 | 2022 |
| A dual-targeting succinate dehydrogenase and F1Fo-ATP synthase inhibitor rapidly sterilizes replicating and non-replicating Mycobacterium tuberculosis C Adolph, CY Cheung, MB McNeil, WJ Jowsey, ZC Williams, K Hards, ... Cell Chemical Biology 31 (4), 683-698. e7, 2024 | 2 | 2024 |
| Identification of Chemical Scaffolds That Inhibit the Mycobacterium tuberculosis Respiratory Complex Succinate Dehydrogenase C Adolph, K Hards, ZC Williams, CY Cheung, LM Keighley, WJ Jowsey, ... ACS infectious diseases, 2024 | | 2024 |
